Gregory J. Keir - Concepedia

Author

Gregory J. Keir

Also Known As

G Keir, G. J. Keir, G. Keir, G.J. Keir, Gregory J Keir, Gregory J. Keir, Gregory John Keir, Gregory Keir, Keir, G, Stephen Adelstein

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Princess Alexandra Hospital Royal Brompton Hospital Royal Prince Alfred Hospital John Hunter Hospital The Alfred Hospital

About

Gregory J. Keir is an author at Princess Alexandra Hospital specializing in pulmonary medicine, pulmonary disease, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	234
2	Pulmonary Disease	3	3	234
3	Pulmonary Medicine	3	3	234
4	Pathology	2	2	190
5	Immunology	1	1	140

Gregory J. Keir

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Rituximab in severe, treatment‐refractory interstitial lung disease Gregory J. Keir, Toby M. Maher, Damien Ming, Respirology	2013	257
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial Toby M. Maher, Veronica A Tudor, Peter Saunders, The Lancet Respiratory Medicine	2022	245
An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study Simon LF Walsh, Athol U. Wells, Nicola Sverzellati, The Lancet Respiratory Medicine	2014	228
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Helen E. Jo, Ian Glaspole, Christopher Grainge, European Respiratory Journal	2017	227
Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants Simon Walsh, Nicola Sverzellati, Anand Devaraj, Thorax	2013	221
Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia Tamera J. Corte, Gregory J. Keir, Konstantinos Dimopoulos, American Journal of Respiratory and Critical Care Medicine	2014	220
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial Peter Saunders, Vicky Tsipouri, Gregory J. Keir, Trials	2017	155
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy Gregory J. Keir, Toby M. Maher, David M. Hansell, European Respiratory Journal Autoimmune DiseaseAdvanced Lung DiseaseLung InflammationMedicineImmunology	2012	140
Deep Learning–based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography Simon Walsh, John A. Mackintosh, Lucio Calandriello, American Journal of Respiratory and Critical Care Medicine	2022	116
Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand* Adelle S. Jee, Robert Sheehy, Peter Hopkins, Respirology	2020	87

Page 1